Kromek Group Plc advanced 5.98% as investors responded positively to the company's continued progress on its radiation and X-ray detector technology. The move places the stock among the stronger performers within the healthcare sector for the session.
Reckitt Benckiser Group plc advanced 4.87% as investors responded positively to the company's continued progress on its a portfolio of consumer health, hygiene and nutrition brands. The move places the stock among the stronger performers within the healthcare sector for the session.
Sareum Holdings plc advanced 4.48% as investors responded positively to the company's continued progress on its a pipeline of oncology and immunology drug candidates. The move places the stock among the stronger performers within the healthcare sector for the session.
Provexis PLC (LSE:PXS) has attracted renewed attention after its shares moved6.86% higher on 1 September 2026. For a relatively small company with aMarket Capitalisationin the tens of millions of pounds and a comparatively limited trading history on many sessions, a percentage move of this …
Reckitt Benckiser has become one of the most closely watched UK consumer-health stocks afterLSE:RKT rose approximately 4.5% on 1 September 2026.
Oxford BioDynamics Plc has emerged as one of the notable percentage gainers among small UK healthcare shares, withLSE:OBD gaining 8.33% on 1 September 2026.
ImmuPharma PLC (LSE:IMM) has attracted renewed investor attention after recording a13.80% gain on 1 September 2026.
Ondine Biomedical has become one of the most closely watched small-cap healthcare names on the London market after announcing a major clinical milestone on 1 September 2026.
Abingdon Health Plc advanced 4.55% as investors responded positively to the company's continued progress on its rapid diagnostic-test development and manufacturing capabilities. The move places the stock among the stronger performers within the healthcare sector for the session.
Oxford Nanopore Technologies (LSE:ONT) shares fell 13.50p to 162.60p, a decline of 7.67% on the day, leaving the company valued at roughly £1,717.62m. The fall places the stock among the day's more significant decliners on the London market. As with many growth-stage technology and …